pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,692 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: grant×type: phase readout×type: filing×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa213
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Ophthalmology5

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05703386: Imaging the Pathogenesis of Cerebral Small Vessel Disease

    Sponsor: Johns Hopkins University. Phase: . Conditions: Ischemic Stroke, Hypertension, Hyperlipidemias, Diabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05832086: Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

    Sponsor: Stephen Freedland. Phase: PHASE2. Conditions: Prostate Adenocarcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07540286: A Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism

    Sponsor: Peking Union Medical College Hospital. Phase: PHASE2. Conditions: Hypoparathyroidism

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07312786: Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors

    Sponsor: Nova Scotia Health Authority. Phase: NA. Conditions: Breast Cancer Survivor, Colorectal Cancer Survivors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05760885: Multisensory Augmentation for Post-stroke Standing Balance

    Sponsor: VA Office of Research and Development. Phase: EARLY_PHASE1. Conditions: Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05016843: The Study of Internet-delivered, Transdiagnostic Treatments for Anxiety and Depression

    Sponsor: Stockholm University. Phase: NA. Conditions: Anxiety Disorders, Depression

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07528326: The TRICURE US IDE Pivotal Study

    Sponsor: TRiCares. Phase: NA. Conditions: Tricuspid Regurgitation (TR)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07442526: AGECTO Study: PCI vs. Optimal Medical Therapy for CTO in the Octogenarian Patients

    Sponsor: San Luigi Gonzaga Hospital. Phase: . Conditions: Coronary Artery Disease (CAD), Chronic Total Occlusion (CTO), Percutaneous Coronary Intervention (PCI), Optimal Medical Therapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06864026: A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

    Sponsor: Eli Lilly and Company. Phase: PHASE4. Conditions: Psoriatic Arthritis, Overweight or Obesity

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07463443: Effectiveness of Chatbot for Improving Caregiving Outcomes in Primary Caregivers of Geriatric Pneumonia Patients: A Study on Knowledge, Attitude and Practice.

    Sponsor: Taipei Veterans General Hospital, Taiwan. Phase: NA. Conditions: Pneumonia, Family Caregivers, Knowledge, Attitudes, Practice, Chatbot, Geriatric Patient

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06648226: Food Swaps to Improve the Healthfulness and Reduce the Carbon Footprint of Grocery Purchases

    Sponsor: Stanford University. Phase: NA. Conditions: Food Selection, Nutrition, Food Preferences, Dietary Habits, Sustainability, Healthy Diet

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07586917: Optimizing Pregnancy and Treatment Interventions for Moms 3.0

    Sponsor: University of Utah. Phase: NA. Conditions: Opioid Abuse (Disorder), Stimulant Use Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07269340: Mandala Painting During Chemotherapy

    Sponsor: Uludag University. Phase: NA. Conditions: Mandala Painting, Chemotherapy, Vomiting, Anxiety, Comfort, Nursing Care

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07379489: Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma

    Sponsor: Tongji Hospital. Phase: . Conditions: HCC, Adjuvant Therapy, Recurrence, Immune Checkpoint Inhibitor

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07592468: Intraoperative CO₂ (Carbon Dioxide)

    Sponsor: Baylor Research Institute. Phase: NA. Conditions: Wound Edges

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04234568: Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Metastatic Digestive System Neuroendocrine Neoplasm, Metastatic Neuroendocrine Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04971850: Sleep-disordered Breathing and Neurocognitive Assessment in Children and Young Adults

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Sleep-disordered Breathing (SDB)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00044174: Dyadic Interactions in Depressed and Non-Depressed Mothers and Their Infants

    Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05874492: Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) Cancer

    Sponsor: Association Francaise pour la Recherche Thermale. Phase: NA. Conditions: Fibrosis, Breast Cancer, Head and Neck Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02387736: DBT for Chronically Self-harming Individuals With BPD: Evaluating the Clinical & Cost Effectiveness of a 6 mo. Treatment

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Borderline Personality Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05642611: Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

    Sponsor: SWOG Cancer Research Network. Phase: PHASE3. Conditions: Malignant Solid Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07516834: Three Dimensional Gait Analysis and Electromyography After Stabilisation of Thoracolumbar Spine Fractures Focusing on Possible Temporal Diferences in Physiological Gait Recovery Through Comparison of Open and Minimally Invasive Approaches.

    Sponsor: Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.. Phase: NA. Conditions: Spine Fracture

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07105709: Open-label Extension Study in Participants With Early Alzheimer's Disease

    Sponsor: GlaxoSmithKline. Phase: PHASE2. Conditions: Alzheimer's Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05634499: A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer

    Sponsor: Hoffmann-La Roche. Phase: PHASE2. Conditions: Endometrial Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02754544: Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Brain Neoplasm, Metastatic Malignant Neoplasm in the Brain, Recurrent Brain Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05665244: Laryngeal Cryotherapy for Refractory Neurogenic Cough

    Sponsor: University of Texas Southwestern Medical Center. Phase: . Conditions: Upper-Airway Cough Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07431034: Internet-Based Cognitive Behavioral Therapy for Insomnia in Persian-Speaking Adults

    Sponsor: Rasool Hamidi Choolabi. Phase: NA. Conditions: Insomnia Disorder, Chronic Insomnia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06575699: Rectus Sheath Block for Analgesia After Gynecological Laparotomy

    Sponsor: Duke University. Phase: PHASE4. Conditions: Gynecologic Surgical Procedures

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04736199: Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer

    Sponsor: Bayer. Phase: PHASE3. Conditions: Prostatic Neoplasms

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06346132: Effect of Virtual Reality on Patient's Comfort During Cardiac Electronic Device Implantation.

    Sponsor: Schlotterbeck Hervé. Phase: NA. Conditions: Virtual Reality, Medical Device, Local Anesthesia, Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07627763: Prospective Dynamic Cohort Study of Phenotypic Profiles in Patients With Chronic Obstructive Pulmonary Disease

    Sponsor: Initiatives Bronchopneumopathie Chronique Obstructive (BPCO). Phase: . Conditions: COPD

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07047521: A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults

    Sponsor: Takeda. Phase: PHASE3. Conditions: Dengue Fever

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07019116: Efficacy of Artificial Intelligence for Gatekeeping in Referrals to Specialized Care

    Sponsor: Hospital de Clinicas de Porto Alegre. Phase: NA. Conditions: Primary Care, Primary Care Patients With Chronic Conditions

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06275906: Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

    Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis. Phase: NA. Conditions: NAFLD, Obesity, IBS

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07299006: Evaluation of Paro, a Therapeutic Assistance Robot in Analgesic Management During the Placement of a Peripheral Intravenous Line in Infants and Children.

    Sponsor: Fondation Lenval. Phase: NA. Conditions: Pain Management

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07051304: Video-Based Versus Numerical Pain Assessment in Postoperative Patients: A Pilot Study

    Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Pain Assessment Scales

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05446584: Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

    Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: Mild Cognitive Impairment, Amnestic Mild Cognitive Disorder, Amnestic Mild Cognitive Impairment, Mild Traumatic Brain Injury, Concussion, Brain

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07318584: Cefotetan Therapy for Escherichia Coli Infections

    Sponsor: Oregon Health and Science University. Phase: PHASE2. Conditions: E Coli Infection, ESBL Producing E.Coli

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07218133: Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery

    Sponsor: Alexander T. Yahanda. Phase: NA. Conditions: Spinal Fusion, Hyperglycemia, Postoperative Pain Management, Postoperative Care, Spine Disease, Neurologic Deficits, Neurological Disorder, Inflammation, Spine Condition, Spinal (Fusion) Surgery, Cytokine Levels, Spine Fusion

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03602833: Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma

    Sponsor: Royal Marsden NHS Foundation Trust. Phase: PHASE1. Conditions: Soft-tissue Sarcoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07586033: Prevalence and Functional Impact of Hand and Wrist Symptoms in Ice Hockey Players

    Sponsor: Dalarna County Council, Sweden. Phase: . Conditions: Hand, Wrist, Overuse Injury, Ice Hockey Players

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07462533: Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing

    Sponsor: Goldman, Butterwick, Fitzpatrick and Groff. Phase: PHASE2. Conditions: Skin Laxity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04279847: Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

    Sponsor: Incyte Corporation. Phase: PHASE1. Conditions: Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome, Myeloproliferative Neoplasm, Relapsed or Refractory Primary Myelofibrosis, Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis), ET (Essential Thrombocythemia)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06627647: A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Non-squamous Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07439848: Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis

    Sponsor: PT. Prodia Stem Cell Indonesia. Phase: PHASE1. Conditions: Acute Respiratory Distress Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07580248: Effects of Supplementation on Performance in Football Players

    Sponsor: Krzysztof Mizera. Phase: NA. Conditions: Physical Performance, Cognitive Performance

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06641765: Continuous Glucose Monitoring in Dialysis Patients With Diabetes

    Sponsor: Bo Feldt-Rasmussen. Phase: NA. Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Continuous Glucose Monitoring, Haemodialysis, Peritoneal Dialysis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05319067: Study of Gut Microbiota Diversity in Children Aged 1-3 Years on Prolonged Antibiotic Prophylaxis for Grade 3 or Higher Vesicoureteral Reflux Compared With 2 Age-matched Control Groups

    Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Vesicoureteral Reflux 3

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04150900: 1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck

    Sponsor: University of Maryland, Baltimore. Phase: PHASE2. Conditions: Squamous Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06053411: Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac

    Sponsor: Washington State University. Phase: EARLY_PHASE1. Conditions: Interaction

    full page →ctgov ↗
    ← prev
    page 54 of 94
    next →